Louvain-la-Neuve, Netherlands

Gaylor Deroissart

This inventor holds 1 USPTO granted patent. Top assignee: Ion Beam Applications S.a.. Active years: 2023.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gaylor Deroissart: Innovator in Hadron Therapy Quality Assurance

Introduction

Gaylor Deroissart is a notable inventor based in Louvain-la-Neuve, NL. He has made significant contributions to the field of medical technology, particularly in hadron therapy. His innovative work focuses on enhancing the quality assurance processes for hadron therapy apparatuses.

Latest Patents

Deroissart holds a patent for a "Phantom and method for the quality assurance of a hadron therapy apparatus." This patent describes a phantom that includes a frame structure with a base plate, energy wedges, and a 2D detector. The design ensures that the components are in known fixed positions relative to the frame structure. The phantom also features a Spread-Out Bragg Peak (SOBP) wedge, which is crucial for determining compliance between planned and actual SOBP. This invention is vital for improving the accuracy and effectiveness of particle therapy in medical treatments.

Career Highlights

Gaylor Deroissart is associated with Ion Beam Applications S.A., a company that specializes in advanced medical technologies. His work at the company has been instrumental in developing innovative solutions for cancer treatment. Deroissart's expertise in hadron therapy has positioned him as a key figure in the field.

Collaborations

Deroissart has collaborated with notable colleagues, including Simon Marcelis and Séverine Rossomme. These partnerships have contributed to the advancement of technology in hadron therapy and have fostered a collaborative environment for innovation.

Conclusion

Gaylor Deroissart's contributions to hadron therapy quality assurance exemplify the impact of innovation in medical technology. His patent and work at Ion Beam Applications S.A. highlight the importance of precision in cancer treatment. Deroissart continues to be a significant figure in the field, driving advancements that improve patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…